Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013)

Lemaitre Vascular (LMAT) reported Deferred Taxes of $2.0 million for Q4 2013, up 48775.0% on a QoQ basis from $4000.0 in Q1 2012.

Lemaitre Vascular (LMAT) has 3 years of Deferred Taxes data on file, last reported at $2.0 million in Q4 2013.

  • Quarterly Deferred Taxes changed N/A year-over-year to $2.0 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was -$286000.0 (changed N/A YoY) and the FY2025 annual result came in at $1.9 million, up 623.14% from the prior year.
  • Deferred Taxes grew to $2.0 million in Q4 2013 per LMAT's latest filing, from $4000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $2.0 million in Q4 2013 and bottomed at -$2.3 million in Q4 2010.
  • The 3-year median for Deferred Taxes is $49000.0 (2010), against an average of -$71500.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -339.30 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -73.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -41.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 43.60 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 40.64 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 29.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -4.57 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2013 1.96 Mn
Mar 31, 2012 4,000.00
Dec 31, 2010 -2.34 Mn
Sep 30, 2010 94,000.00